Eric Richman, Director at Altimmune, holds 63.83K shares in NeuBase Therapeutics (Ticker: NBSE), holds 44.03K shares in ADMA Biologics (Ticker: ADMA), holds 186.82K shares in Altimmune (Ticker: ALT). Most recently, Eric Richman Bought ― shares of NeuBase Therapeutics on May 04, 2020 for an estimated value of 65.00K.